Skip to main content
[Preprint]. 2025 Apr 22:2025.04.22.25326208. [Version 1] doi: 10.1101/2025.04.22.25326208

Table 3.

Venetoclax plasma PK parameters (geometric mean (geometric standard deviation)).

D1 D15 D29

Dose (mg) Cmax (μg/L) Cmax/Dose (μg/L/mg) Tmax (h) t½ (h) AUC0-last (mg/L·h) AUC0-infa (mg/L·h) Cl/F (L/h) Cmin (μg/L) Cmaxb (μg/L) AUC0–24b (mg/L·h) Ratioc D29/D1

400 (N=3) 658 (1.29) 1.64 (1.29) 5.2 (1.3) 11 (1.2) 8.02 (1.21) 11.1 (1.27) 36.2 (1.27) 180 (1.72) 968 (1.67) 10.5 (1.65) 0.95 (1.99)
600 (N=3) 1172 (1.79) 1.95 (1.79) 5.6 (1.5) 6.6 (1.4) 12.2 (1.65) 14.6 (1.65) 41.2 (1.65) 214 (2.30) 554 (4.89) 9.11 (4.1) 0.62 (5.32)
800 (N=4) 979 (1.50) 1.22 (1.50) 6.9 (1.2) 9.4 (1.8) 8.76 (1.54) 16.6 (2.31) 48.1 (2.31) 177 (2.89) 1000 (-) 8.87 0.79

Total (N=10) 917 (1.57) 1.54 (1.54) 6.0 (1.3) 8.9 (1.6) - - 42.1 (1.76) 188 (2.17) 765 (2.74) 0.77 (2.90)
a

AUC0-inf extrapolated beyond the last time point sampled was geometric mean 20% (range 4.9–84%).

b

N=3, 3, and 1 respectively for the 400, 600, and 800 mg dose.

c

Ratio of day 29 AUC0–24 over day 1 AUC0-inf.